Skip to main navigation Skip to search Skip to main content

Overcoming acquired resistance of gefitinib in lung cancer cells without T790M by AZD9291 or Twist1 knockdown in vitro and in vivo

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1555-1571
Number of pages17
JournalArchives of Toxicology
Volume93
Issue number6
DOIs
StatePublished - Jun 1 2019
Externally publishedYes

ASJC Scopus Subject Areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Keywords

  • AZD9291
  • Drug resistance
  • EGFR-TKI
  • Gefitinib
  • p-AKT
  • Twist1

Cite this